Hem › Icke-småcellig lungcancer › Florida › Sarasota
Kliniska studier för Icke-småcellig lungcancer i Sarasota, FL
17 studier för Icke-småcellig lungcancer söker deltagare vid platser i och runt Sarasota (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
RekryterarFas 1
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RekryterarFas 1
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RekryterarFas 3
- Florida Cancer Specialists, Sarasota
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekryterarFas 1/2
- Florida Cancer Specialists, Sarasota
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RekryterarFas 1/2
- Florida Cancer Specialists & Research Institute - Sarasota, Sarasota
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
RekryterarFas 2/3
- Local Institution - 007-922-I, Sarasota
- Local Institution - 007-922-J, Sarasota
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
RekryterarFas 1/2
- Florida Cancer Specialists, Sarasota
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- Florida Cancer Specalists, Sarasota
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
RekryterarFas 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
RekryterarFas 1
- Florida Cancer Specialists, Sarasota
A Study of LY4175408 in Participants With Advanced Cancer
RekryterarFas 1
- Florida Cancer Specialists - Sarasota, Sarasota
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekryterarFas 1
- Florida Cancer Specialists, Sarasota
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
RekryterarFas 1
- Florida Cancer Specialists, Sarasota
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RekryterarFas 1
- Florida Cancer Specialists, Sarasota
A Study of DB-1310 in Advanced/Metastatic Solid Tumors
RekryterarFas 1/2
- Florida Cancer Specialists, Sarasota
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- Florida Cancer Specialists, Sarasota
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekryterarFas 1
- Dren Investigational Site, Sarasota
Icke-småcellig lungcancer-studier i andra städer
- Houston, TX145 studier
- New York City, NY121 studier
- Arlington, VA104 studier
- Nashville, TN97 studier
- Boston, MA90 studier
- Los Angeles, CA87 studier
- St. Louis, MO73 studier
- Chicago, IL61 studier
- Baltimore, MD60 studier
- San Antonio, TX59 studier
- Columbus, OH57 studier
- Washington, DC55 studier
Andra studier i Sarasota
- Metastaserande cancer19 studier
- Kolorektal cancer16 studier
- Äggstockscancer16 studier
- Endometriecancer14 studier
- Bröstcancer12 studier
- Cancer (alla typer)11 studier
- Triplenegativ bröstcancer8 studier
- Lungcancer7 studier
- Bukspottkörtelcancer7 studier
- Atrial fibrillation7 studier
- Prostatacancer6 studier
- Steatotisk leversjukdom6 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.